Newsbot

EAT heads into Q2 earnings with revenue growth led by Chilis, even as Maggianos softness and cost pressures weigh on margins.

Defense stocks are rallying as U.S. defense priorities sharpen, putting KTOS, HII and TDY in focus amid expectations for higher spending and modernization.

STX heads into Jan. 27 earnings with revenue expected to rise 16% YoY, strong AI-driven data center demand and solid margins.

CSX posts a 7% EPS drop in fourth-quarter 2025 as weak shipping demand and rising costs drag earnings and revenues below estimates.

Commerce Bancshares tops Q4 estimates with strong NII and fee income gains, but shares slip on rising credit loss provisions.

Columbia Banking Systems Q4 earnings beat forecasts as revenues jumped 47% and provisions fell, despite rising expenses.

F5 heads into Q1 FY26 earnings with EPS projected to be $3.35-$3.85 as product demand, subscriptions and systems refresh shape results.

The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $4.73, representing a -4.64% change from its previous close.

SLM posts Q4 EPS of $1.12, up from 50 cents a year ago, driven by higher NII and non-interest income despite rising expenses.

West Pharmaceutical debuts the Synchrony S1 prefillable syringe at Pharmapack 2026, enhancing biologics, vaccines and home-care support.

Nothing can move a stock faster, up or down, than an earnings announcement. So with the season about to heat up, Dave Bartosiak offers 3 proven secrets to find stocks poised to beat expectations and surge on the news.

ARM faces pressure as a premium valuation demands near-term proof, with delayed licensing revenues and thin patience testing todays expectations.

BKD, ITUB and VALE top a breakout-stock screen for 2026 after strong 2025 gains, with prices near resistance levels hinting at further upside.

Sub-$10 energy plays WTI, RES and OIS offer diverse exposure as oil hovers near $60 and investors eye select opportunities.

INTC beats Q4 estimates with AI PC traction and strong product launches, but supply woes hit revenue and soft guidance weighs on it.

TCBI beats Q4 earnings estimates as net interest income jumps, margins expand and capital strengthens despite higher expenses.

MSTR shares are down over 50% as Bitcoin slides, but strong fundamentals and its BTC-heavy strategy could set Strategy up for a rebound.

AeroVironment (AVAV) closed the most recent trading day at $307.75, moving 1.4% from the previous trading session.

TMO heads into Q4 earnings with Specialty Diagnostics growth, fresh FDA approvals and launches that could lift results on Jan. 29.

Baker Hughes Q4 results face pressure from weaker oil prices, but a recent acquisition may help offset macro headwinds.

MKCs fourth-quarter earnings miss estimates, but organic growth improves on gains in Consumer and Flavor Solutions.

Intel stock is selling off following its earnings report, but is there more to this story?

Five kids do not make you tax-exempt, but they can slash your tax bill considerably. Here is how child tax credits really work and who qualifies.